Esperion Therapeutics Inc (ESPR)
2.045
+0.08
(+3.81%)
USD |
NASDAQ |
May 01, 16:00
2.06
+0.02
(+0.73%)
After-Hours: 20:00
Esperion Therapeutics Accounts Payable (Quarterly): 31.72M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.72M |
September 30, 2023 | 26.21M |
June 30, 2023 | 24.56M |
March 31, 2023 | 17.06M |
December 31, 2022 | 23.04M |
September 30, 2022 | 18.58M |
June 30, 2022 | 12.83M |
March 31, 2022 | 26.83M |
December 31, 2021 | 17.56M |
September 30, 2021 | 20.74M |
June 30, 2021 | 29.35M |
March 31, 2021 | 30.34M |
December 31, 2020 | 51.98M |
September 30, 2020 | 17.58M |
June 30, 2020 | 29.69M |
March 31, 2020 | 15.11M |
December 31, 2019 | 28.86M |
September 30, 2019 | 23.74M |
June 30, 2019 | 28.40M |
March 31, 2019 | 33.27M |
December 31, 2018 | 44.89M |
September 30, 2018 | 18.63M |
June 30, 2018 | 22.48M |
Date | Value |
---|---|
March 31, 2018 | 11.96M |
December 31, 2017 | 20.38M |
September 30, 2017 | 19.50M |
June 30, 2017 | 18.71M |
March 31, 2017 | 11.64M |
December 31, 2016 | 4.595M |
September 30, 2016 | 1.783M |
June 30, 2016 | 1.566M |
March 31, 2016 | 1.54M |
December 31, 2015 | 0.707M |
September 30, 2015 | 1.979M |
June 30, 2015 | 3.305M |
March 31, 2015 | 2.899M |
December 31, 2014 | 2.04M |
September 30, 2014 | 3.299M |
June 30, 2014 | 4.211M |
March 31, 2014 | 2.098M |
December 31, 2013 | 2.232M |
September 30, 2013 | 1.945M |
June 30, 2013 | 1.656M |
March 31, 2013 | 0.9268M |
December 31, 2012 | 0.4763M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
12.83M
Minimum
Jun 2022
51.98M
Maximum
Dec 2020
24.96M
Average
24.56M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
United Therapeutics Corp | 5.60M |
Dynavax Technologies Corp | 5.245M |
Heron Therapeutics Inc | 3.799M |
Aldeyra Therapeutics Inc | 1.338M |
Deciphera Pharmaceuticals Inc | 26.48M |